Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
Genoveva Uzunova, Former Senior Staff Associate at Columbia University in the City of New York, shared a post on LinkedIn:
“Today marks Sex Diff Day and Mental Health Awareness Week – a perfect time to discuss a gap in our healthcare system:
Sex as a Biological Variable (SABV).
As both a psychiatrist and a genetherapy researcher, I’ve seen how ignoring sex differences, from brain stereotaxic coordinates in the lab to diagnostic scales in the psychiatry clinic, may lead to missed targets and missed diagnoses.
In this video, I explore why men’s depression often ‘masks’ as irritability, and why structural brain differences mean we must move toward truly precision psychiatry.
We cannot provide better care until we do better, sex-specific science.
We know that the brains of female mice have many neuroanatomical and gene expression differences with the brains of male mice, which may translate into different behaviors.
Diseases such as depression, anxiety, autism, Alzheimer’s disease, multiple sclerosis, Systemic lupus erythematosus (SLE), and breast cancer have higher rates in women than in men.
In connection with today, my dear Mom, Anelia Uzunova, published a letter in Nature in 1976 with her co-authors Estelle Ramey and Peter Ramwell, on the Effect of testosterone, sex and age on experimentally induced arterial thrombosis.
My views in this presentation are based on my professional experience and literature searches.
I have discussed many of them, particularly relating to gene therapy and depression, with my supervisors but have met with some resistance as this will complicate the studies and work.
When I researched brain gene therapies for neurodegenerative disorders, I measured the Bregma-Lambda distances in our four transgenic mouse strains and found differences between strains and males and females.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 07:38Baraa Nassar: High Clinical Suspicion Is Essential for Early Diagnosis of CVST
-
Jun 26, 2026, 07:10Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
-
Jun 26, 2026, 06:01Nicolas Hubacz: A Sharper Look at the Brain’s Vascular Landscape
-
Jun 26, 2026, 05:57Ayse Bahar Keleşoğlu Dinçer: New Insights into Antiphospholipid Syndrome Classification and Recurrent Thrombosis Risk
-
Jun 26, 2026, 05:55Shinya Goto: How Newton’s Laws Shape Platelet Function
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis
-
Jun 26, 2026, 05:26Maxime Dely: Strengthening Skills in Plasma and Red Cell Exchange
-
Jun 26, 2026, 05:26Andreas Calatzis: Hidden Differences in Anti-Xa Testing